-
1
-
-
0018691869
-
Platelet activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl- 3-phosphorylcholine as the active component (a new class of lipid chemical mediators)
-
DEMOPOULOS CA, PINCKARD RN, HANAHAN DJ. Platelet activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl- 3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J Biol Chem 1979; 254: 9355-9358.
-
(1979)
J Biol Chem
, vol.254
, pp. 9355-9358
-
-
Demopoulos, C.A.1
Pinckard, R.N.2
Hanahan, D.J.3
-
2
-
-
0019265954
-
Molecular pathobiology of acetyl glyceryl ether phosphorylcholine: Evidence for the structural and functional identity with plateletactivating factor
-
PINCKARD RN, MCMANUS LM, DEMOPOULOS CA, HALONEN M, CLARK PO et al. Molecular pathobiology of acetyl glyceryl ether phosphorylcholine: evidence for the structural and functional identity with plateletactivating factor. J Reticuloendothel Soc 1980; 28: 95-103.
-
(1980)
J Reticuloendothel Soc
, vol.28
, pp. 95-103
-
-
Pinckard, R.N.1
McManus, L.M.2
Demopoulos, C.A.3
Halonen, M.4
Clark, P.O.5
-
3
-
-
77953292881
-
Te platelet activating factor (PAF) signaling cascade in systemic inflammatory responses
-
YOST CC, WEYRICH AS, ZIMMERMAN GA. Te platelet activating factor (PAF) signaling cascade in systemic inflammatory responses. Biochimie 2010; 92: 692-697. http://dx.doi.org/10.1016/j.biochi.2010.02.011
-
(2010)
Biochimie
, vol.92
, pp. 692-697
-
-
Yost, C.C.1
Weyrich, A.S.2
Zimmerman, G.A.3
-
5
-
-
58649117121
-
Emerging roles of PAR-1 and PAFR in melanoma metastasis
-
MELNIKOVA VO, VILLARES GJ, BAR-ELI M. Emerging roles of PAR-1 and PAFR in melanoma metastasis. Cancer Microenviron 2008; 1: 103-111. http://dx.doi.org/10.1007/s12307-008-0002-7
-
(2008)
Cancer Microenviron
, vol.1
, pp. 103-111
-
-
Melnikova, V.O.1
Villares, G.J.2
Bar-Eli, M.3
-
6
-
-
0031065163
-
Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages
-
Camussi G, Montrucchio G, Lupia E, Soldi R, COMOGLIO PM et al. Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages. J Immunol 1997; 158: 1302-1309.
-
(1997)
J Immunol
, vol.158
, pp. 1302-1309
-
-
Camussi, G.1
Montrucchio, G.2
Lupia, E.3
Soldi, R.4
Comoglio, P.M.5
-
7
-
-
0038607977
-
Te epidermal platelet activating factor receptor augments chemotherapy-induced apoptosis in human carcinoma cell lines
-
LI T, SOUTHALL MD, YI Q, PEI Y, LEWIS D et al. Te epidermal platelet activating factor receptor augments chemotherapy-induced apoptosis in human carcinoma cell lines. J Biol Chem 2003; 278: 16614-16621. http://dx.doi.org/10.1074/jbc.M211287200
-
(2003)
J Biol Chem
, vol.278
, pp. 16614-16621
-
-
Li, T.1
Southall, M.D.2
Yi, Q.3
Pei, Y.4
Lewis, D.5
-
8
-
-
79952072157
-
Transcriptional control of melanoma metastasis: The importance of the tumor microenvironment
-
BRAEUER RR, ZIGLER M, VILLARES GJ, DOBROFF AS, BAR-ELI M. Transcriptional control of melanoma metastasis: the importance of the tumor microenvironment. Semin Cancer Biol 2011; 21: 83-88. http://dx.doi.org/10.1016/j.semcancer.2010.12.007
-
(2011)
Semin Cancer Biol
, vol.21
, pp. 83-88
-
-
Braeuer, R.R.1
Zigler, M.2
Villares, G.J.3
Dobroff, A.S.4
Bar-Eli, M.5
-
9
-
-
0029582870
-
Platelet-activating factor receptor: Gene expression and signal transduction
-
IZUMI T, SHIMIZU T. Platelet-activating factor receptor: gene expression and signal transduction. Biochim Biophys Acta 1995; 1259: 317-333 http://dx.doi.org/10.1016/0005-2760(95)00171-9
-
(1995)
Biochim Biophys Acta
, vol.1259
, pp. 317-333
-
-
Izumi, T.1
Shimizu, T.2
-
10
-
-
0035968169
-
Gprotein- independent activation of Tyk2 by the platelet-activating factor receptor
-
LUKASHOVA V, ASSELIN C, KROLEWSKI JJ, ROLA-PLESZCZYNSKI M, STANKOVA J. Gprotein- independent activation of Tyk2 by the platelet-activating factor receptor. J Biol Chem 2001; 276: 24113-24121. http://dx.doi.org/10.1074/jbc.M100720200
-
(2001)
J Biol Chem
, vol.276
, pp. 24113-24121
-
-
Lukashova, V.1
Asselin, C.2
Krolewski J.J.Rola-Pleszczynski, M.3
Stankova, J.4
-
11
-
-
48249142418
-
Ty- rosine phosphorylation regulates the partitioning of STAT1 between different dimmer conformations
-
WENTA N, STRAUSS H, MEYER S, VINKEMEIER U. Ty- rosine phosphorylation regulates the partitioning of STAT1 between different dimmer conformations. Proc Natl Acad Sci USA 2008; 105: 9238-9243. http://dx.doi.org/10.1073/pnas.0802130105
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, pp. 9238-9243
-
-
Wenta, N.1
Strauss, H.2
Meyer, S.3
Vinkemeier, U.4
-
12
-
-
5644266041
-
Diverse proteomic alteration in gastric adenocarcinoma
-
HE QY, CHEUNG YH, LEUNG SY, YUEN ST, CHU KM et al. Diverse proteomic alteration in gastric adenocarcinoma. Proteomics 2004; 4: 3276-3287. http://dx.doi.org/10.1002/pmic.200300916
-
(2004)
Proteomics
, vol.4
, pp. 3276-3287
-
-
He, Q.Y.1
Cheung, Y.H.2
Leung, S.Y.3
Yuen, S.T.4
Chu, K.M.5
-
13
-
-
33748678896
-
Gastric cancer: Global pattern of the disease and an overview of environmental risk factors
-
FORMAN D, BARLEY VJ. Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Practice Res Clin Gastroenterol 2006; 20: 633-649. http://dx.doi.org/10.1016/j.bpg.2006.04.008
-
(2006)
Best Practice Res Clin Gastroenterol
, vol.20
, pp. 633-649
-
-
Forman, D.1
Barley, V.J.2
-
14
-
-
0043200978
-
Gastric cancer
-
HOHENBERGER P, GRETSCHEL S. Gastric cancer. Lancet 2003; 362: 305-315. http://dx.doi.org/10.1016/S0140-6736(03)13975-X
-
(2003)
Lancet
, vol.362
, pp. 305-315
-
-
Hohenberger, P.1
Gretschel, S.2
-
15
-
-
84865510127
-
Inflammation-associated cancer development in digestive organs: Mechanisms and roles for genetic and epigenetic modulation
-
CHIBA T, MARUSAWA H, USHIJIMA T. Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterol 2012; 143: 550-563. http://dx.doi.org/10.1053/j.gastro.2012.07.009
-
(2012)
Gastroenterol
, vol.143
, pp. 550-563
-
-
Chiba, T.1
Marusawa, H.2
Ushijima, T.3
-
16
-
-
84859940334
-
Multifactorial etiology of gastric cancer
-
ZABALETA J. Multifactorial etiology of gastric cancer. Methods Mol Biol. 2012; 863: 411-435. http://dx.doi.org/10.1007/978-1-61779-612-8_26
-
(2012)
Methods Mol Biol
, vol.863
, pp. 411-435
-
-
Zabaleta, J.1
-
17
-
-
78650548230
-
Roles of inflammatory cytokines in the progression of gastric cancer: Friends or foes?
-
Tsujimoto H, Ono S, Ichikura T, Matsumoto Y, Yamamoto J et al. Roles of inflammatory cytokines in the progression of gastric cancer: friends or foes? Gastric Cancer 2010; 13: 212-221. http://dx.doi.org/10.1007/s10120-010-0568-x
-
(2010)
Gastric Cancer
, vol.13
, pp. 212-221
-
-
Tsujimoto, H.1
Ono, S.2
Ichikura, T.3
Matsumoto, Y.4
Yamamoto, J.5
-
18
-
-
84864545633
-
Molecular link mechanisms between inflammation and cancer
-
VENDRAMINI-COSTA DB, CARVALHO JE. Molecular link mechanisms between inflammation and cancer. Curr Pharm Des 2012; 18: 3831-3852 http://dx.doi.org/10.2174/138161212802083707
-
(2012)
Curr Pharm Des
, vol.18
, pp. 3831-3852
-
-
Vendramini-Costa, D.B.1
Carvalho, J.E.2
-
19
-
-
0036594254
-
Platelet-activating factor receptor
-
HONDA Z-I, ISHII S, SHIMIZU T. Platelet-activating factor receptor. J Biochem 2002; 131: 773-779. http://dx.doi.org/10.1093/oxfordjournals.jbchem.a003164
-
(2002)
J Biochem
, vol.131
, pp. 773-779
-
-
Honda, Z.-I.1
Ishii, S.2
Shimizu, T.3
-
20
-
-
56049128147
-
Te role of platelet-activating factor in the mammalian female reproductive tract
-
TIEMANN U. Te role of platelet-activating factor in the mammalian female reproductive tract. Reprod Domest Anim. 2008; 43: 647-655. http://dx.doi.org/10.1111/j.1439-0531.2007.00959.x
-
(2008)
Reprod Domest Anim
, vol.43
, pp. 647-655
-
-
Tiemann, U.1
-
21
-
-
70349336797
-
Platelet activating factor/platelet activating factor receptor pathway as a potential therapeutic target in autoimmune diseases
-
EDWARDS LJ, CONSTANTINESCU CS. Platelet activating factor/platelet activating factor receptor pathway as a potential therapeutic target in autoimmune diseases. Inflamm Allergy Drug Targets 2009; 8: 182-190. http://dx.doi.org/10.2174/187152809788681010
-
(2009)
Inflamm Allergy Drug Targets
, vol.8
, pp. 182-190
-
-
Edwards, L.J.1
Constantinescu, C.S.2
-
22
-
-
36148957474
-
Inflammation and melanoma growth and metastasis: The role of platelet-activating factor (PAF) and its receptor
-
MELNIKOVA V, BAR-ELI M. Inflammation and melanoma growth and metastasis: the role of platelet-activating factor (PAF) and its receptor. Cancer Metastasis Rev 2007; 26: 359-371. http://dx.doi.org/10.1007/s10555-007-9092-9
-
(2007)
Cancer Metastasis Rev
, vol.26
, pp. 359-371
-
-
Melnikova, V.1
Bar-Eli, M.2
-
23
-
-
70349540689
-
Te implication of platelet activating factor in cancer growth and metastasis: Potent beneficial roleofPAF-inhibitors and antioxidants
-
TSOUPRAS AB, IATROU C, FRANGIA C, DEMOPOULOS CA. Te implication of platelet activating factor in cancer growth and metastasis: potent beneficial roleofPAF-inhibitors and antioxidants. Infect Disord Drug Targets 2009; 9: 390-399. http://dx.doi.org/10.2174/187152609788922555
-
(2009)
Infect Disord Drug Targets
, vol.9
, pp. 390-399
-
-
Tsoupras, A.B.1
Iatrou, C.2
Frangia, C.3
Demopoulos, C.A.4
-
24
-
-
0028129491
-
Platelet-activating factor mediates an autocrine prolifera-tive loop in endometrial adenocarcinoma cell line HEC-1A
-
Maggi M, Bonaccorsi L, Finetti G, Carloni V, Muratori M et al. Platelet-activating factor mediates an autocrine prolifera-tive loop in endometrial adenocarcinoma cell line HEC-1A. Cancer Res. 1994; 54: 4777-4784.
-
(1994)
Cancer Res
, vol.54
, pp. 4777-4784
-
-
Maggi, M.1
Bonaccorsi, L.2
Finetti, G.3
Carloni, V.4
Muratori, M.5
-
25
-
-
0033694711
-
PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis
-
BUSSOLATI B, BIANCONE L, CASSONI P, RUSSO S, ROLA PLESZCZYNSKI M et al. PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis. Am J Pathol 2000; 157: 1713-1725. http://dx.doi.org/10.1016/S0002-9440(10)64808-0
-
(2000)
Am J Pathol
, vol.157
, pp. 1713-1725
-
-
Bussolati, B.1
Biancone, L.2
Cassoni, P.3
Russo, S.4
Rola Pleszczynski, M.5
-
26
-
-
0035137362
-
Interaction of tumor cells with vascular endothelia: Role of platelet-activating factor
-
MANNORI G, BARLETTA E, MUGNAI G, RUGGIERI S. Interaction of tumor cells with vascular endothelia: role of platelet-activating factor. Clin Exp Metastasis 2000; 18: 89-96. http://dx.doi.org/10.1023/A:1026548700247
-
(2000)
Clin Exp Metastasis
, vol.18
, pp. 89-96
-
-
Mannori, G.1
Barletta, E.2
Mugnai, G.3
Ruggieri, S.4
-
27
-
-
0026093667
-
Platelet-activating factor induces expression of early response genes c-fos and TIS-1 in human epidermoid carcinoma A-431 cells
-
TRIPATHI YB, KANDALA JC, GUNTAKA RV, LIM RW, SHUKLA SD. Platelet-activating factor induces expression of early response genes c-fos and TIS-1 in human epidermoid carcinoma A-431 cells. Life Sci. 1991; 49: 1761-1767. http://dx.doi.org/10.1016/0024-3205(91)90319-7
-
(1991)
Life Sci
, vol.49
, pp. 1761-1767
-
-
Tripathi, Y.B.1
Kandala, J.C.2
Guntaka, R.V.3
Lim, R.W.4
Shukla, S.D.5
-
28
-
-
0033964460
-
Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model
-
MONTRUCCHIO G, LUPIA E, BATTAGLIA E, DEL SORBO L, BOCCELLINO M. Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model. Arterioscl Tromb Vasc Biol 2000; 20: 80-88. http://dx.doi.org/10.1161/01.ATV.20.1.80
-
(2000)
Arterioscl Tromb Vasc Biol
, vol.20
, pp. 80-88
-
-
Montrucchio, G.1
Lupia, E.2
Battaglia, E.3
Del Sorbo, L.4
Boccellino, M.5
-
29
-
-
0031769314
-
Potential angiogenic role of platelet-activating factor in human breast cancer
-
MONTRUCCHIO G, SAPINO A, BUSSOLATI B, GHISOLFI G, RIZEA-SAVU S et al. Potential angiogenic role of platelet-activating factor in human breast cancer. Am J Pathol 1998; 153: 1589-1596. http://dx.doi.org/10.1016/S0002-9440(10)65747-1
-
(1998)
Am J Pathol
, vol.153
, pp. 1589-1596
-
-
Montrucchio, G.1
Sapino, A.2
Bussolati, B.3
Ghisolfi, G.4
Rizea-Savu, S.5
-
30
-
-
0030756944
-
VEGF effectonvascular permeability is mediated by synthesis of platelet-activating factor
-
SIROIS MG, EDELMAN ER. VEGF effectonvascular permeability is mediated by synthesis of platelet-activating factor. Am J Physiol. 1997; 272: H2746-H2756.
-
(1997)
Am J Physiol
, vol.272
-
-
Sirois, M.G.1
Edelman, E.R.2
-
31
-
-
0037077235
-
Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells
-
DEO DD, AXELRAD TW, ROBERT EG, MARCHESELLI V, BAZAN NG et al. Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells. J Biol Chem 2002; 277: 21237-21245. http://dx.doi.org/10.1074/jbc.M110955200
-
(2002)
J Biol Chem
, vol.277
, pp. 21237-21245
-
-
Deo, D.D.1
Axelrad, T.W.2
Robert, E.G.3
Marcheselli, V.4
Bazan, N.G.5
-
32
-
-
77954642715
-
Activated networking of platelet activating factor receptor and FAK/STAT1 induces malignant potential in BRCA1-mutant at-risk ovarian epithelium
-
ZHANG L, WANG D, JIANG W, EDWARDS D, QIU W et al. Activated networking of platelet activating factor receptor and FAK/STAT1 induces malignant potential in BRCA1-mutant at-risk ovarian epithelium. Reprod Biol Endocrinol 2010; 8: 74. http://dx.doi.org/10.1186/1477-7827-8-74
-
(2010)
Reprod Biol Endocrinol
, vol.8
, pp. 74
-
-
Zhang, L.1
Wang, D.2
Jiang, W.3
Edwards, D.4
Qiu, W.5
-
33
-
-
0031023828
-
Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor
-
ISHII S, NAGASE T, TASHIRO F, IKUTA K, SATO S et al. Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor. EMBO J 1997; 16: 133-142. http://dx.doi.org/10.1093/emboj/16.1.133
-
(1997)
EMBO J
, vol.16
, pp. 133-142
-
-
Ishii, S.1
Nagase, T.2
Tashiro, F.3
Ikuta, K.4
Sato, S.5
-
34
-
-
0141455127
-
Platelet-activating factor inactivation by local expression of platelet-activating factor acetylhydrolase modifies tumor vascularization and growth
-
Biancone L, Cantaluppi V, Del Sorbo L, Russo S, TJOELKER LW et al. Platelet-activating factor inactivation by local expression of platelet-activating factor acetylhydrolase modifies tumor vascularization and growth. Clin Cancer Res 2003; 9: 4214-4220.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 4214-4220
-
-
Biancone, L.1
Cantaluppi, V.2
Del Sorbo, L.3
Russo, S.4
Tjoelker, L.W.5
-
35
-
-
70350398248
-
Crosstalk between protease-activated receptor 1 and platelet activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis
-
MELNIKOVA VO, BALASUBRAMANIAN K, VILLARES GJ, DOBROFF AS, ZIGLER M et al. Crosstalk between protease-activated receptor 1 and platelet activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis. J Biol Chem 2009; 284: 28845-28855. http://dx.doi.org/10.1074/jbc.M109.042150
-
(2009)
J Biol Chem
, vol.284
, pp. 28845-28855
-
-
Melnikova, V.O.1
Balasubramanian, K.2
Villares, G.J.3
Dobroff, A.S.4
Zigler, M.5
-
36
-
-
0034904022
-
Is there a role of platelet-activating factor in human lung cancer?
-
Denizot Y, Desplat V, Drouet M, Bertin F, Melloni B. Is there a role of platelet-activating factor in human lung cancer? Lung Cancer 2001; 33: 195-202. http://dx.doi.org/10.1016/S0169-5002(01)00197-0
-
(2001)
Lung Cancer
, vol.33
, pp. 195-202
-
-
Denizot, Y.1
Desplat, V.2
Drouet, M.3
Bertin, F.4
Melloni, B.5
-
37
-
-
0242636454
-
Tissue concentrations of platelet-activating factor in colorectal carcinoma: Inverse relationships with Dukes'stage of patients
-
DENIZOT Y, GAINANT A, GUGLIELMI L, BOUVIER S, CUBERTAFOND P et al. Tissue concentrations of platelet-activating factor in colorectal carcinoma: inverse relationships with Dukes'stage of patients. Oncogene 2003; 22: 7222-7224. http://dx.doi.org/10.1038/sj.onc.1207032
-
(2003)
Oncogene
, vol.22
, pp. 7222-7224
-
-
Denizot, Y.1
Gainant, A.2
Guglielmi, L.3
Bouvier, S.4
Cubertafond, P.5
-
38
-
-
22744459601
-
Platelet-activating factor and human thyroid cancer
-
DENIZOT Y, CHIANEA T, LABROUSSE F, TRUFFINET V, DELAGE M et al. Platelet-activating factor and human thyroid cancer. Eur J Endocrinol. 2005; 153: 31-40. http://dx.doi.org/10.1530/eje.1.01947
-
(2005)
Eur J Endocrinol
, vol.153
, pp. 31-40
-
-
Denizot, Y.1
Chianea, T.2
Labrousse, F.3
Truffinet, V.4
Delage, M.5
-
39
-
-
0024444621
-
Presence of PAF-acether in human breast carcinoma: Relation to axillary lymph node metastasis
-
Pitton C, Lanson M, Besson P, et al. Presence of PAF-acether in human breast carcinoma: relation to axillary lymph node metastasis. J Natl Cancer Inst. 1989; 81: 1298-1302. http://dx.doi.org/10.1093/jnci/81.17.1298
-
(1989)
J Natl Cancer Inst
, vol.81
, pp. 1298-1302
-
-
Pitton, C.1
Lanson, M.2
Besson, P.3
-
40
-
-
48649091326
-
Activation of platelet-activating factor receptor and pleio-tropic effectson tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer
-
APONTE M, JIANG W, LAKKIS M, LI MJ, EDWARDS D et al. Activation of platelet-activating factor receptor and pleio-tropic effectson tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer. Cancer Res 2008; 68: 5839-5848. http://dx.doi.org/10.1158/0008-5472.CAN-07-5771
-
(2008)
Cancer Res
, vol.68
, pp. 5839-5848
-
-
Aponte, M.1
Jiang, W.2
Lakkis, M.3
Li, M.J.4
Edwards, D.5
-
41
-
-
39049087028
-
Expression of platelet-activating factor receptor: A novel prognosticator in patients with hepatocellular carcinoma following hepatectomy
-
KITAGAWA D, TAKETOMI A, KAYASHIMA H, KURODA Y, ITOH S et al. Expression of platelet-activating factor receptor: a novel prognosticator in patients with hepatocellular carcinoma following hepatectomy. Oncology 2007; 72: 381-387. http://dx.doi.org/10.1159/000113149
-
(2007)
Oncology
, vol.72
, pp. 381-387
-
-
Kitagawa, D.1
Taketomi, A.2
Kayashima, H.3
Kuroda, Y.4
Itoh, S.5
-
42
-
-
33744460256
-
Platelet-activating factor in cirrhotic liver and hepatocel-lular carcinoma
-
Mathonnet M, Descottes B, Valleix D, Truffinet V, Labrousse F et al. Platelet-activating factor in cirrhotic liver and hepatocel-lular carcinoma. World J Gastroenterol 2006; 12: 2773-2778.
-
(2006)
World J Gastroenterol
, vol.12
, pp. 2773-2778
-
-
Mathonnet, M.1
Descottes, B.2
Valleix, D.3
Truffinet, V.4
Labrousse, F.5
-
43
-
-
84861029935
-
Expression of PAFR as Part of a Prosurvival Response to Chemotherapy: A Novel Target for Combination TerapyinMelanoma
-
2012
-
ONUCHIC AC, MACHADO CML, SAITO RF, RIOS FJ, JANCAR S et al. Expression of PAFR as Part of a Prosurvival Response to Chemotherapy: A Novel Target for Combination TerapyinMelanoma. Mediators Inflamm 2012;2012:175408. http://dx.doi.org/10.1155/2012/175408
-
(2012)
Mediators Inflamm
, pp. 175408
-
-
Onuchic, A.C.1
Machado, C.M.L.2
Saito, R.F.3
Rios, F.J.4
Jancar, S.5
-
44
-
-
12644292106
-
Te two histological main typesofgastric carcinoma: Diffuse and so-called intestinal-type carcinoma
-
Lauren P. Te two histological main typesofgastric carcinoma: diffuse and so-called intestinal-type carcinoma. Act Pathol Microbiol Scand. 1965; 64: 31-49.
-
(1965)
Act Pathol Microbiol Scand
, vol.64
, pp. 31-49
-
-
Lauren, P.1
-
46
-
-
61349167824
-
Heat Shock Pro-tein-27, -60 and -90 expression in gastric cancer: Association with clinicopathological variables and patient survival
-
GIAGINIS C, DASKALOPOULOU SS, VGENOPOULOU S, SFINIADAKIS I, KOURAKLIS G et al. Heat Shock Pro-tein-27, -60 and -90 expression in gastric cancer: association with clinicopathological variables and patient survival. BMC Gastroenterol. 2009; 9: 14. http://dx.doi.org/10.1186/1471-230X-9-14
-
(2009)
BMC Gastroenterol
, vol.9
, pp. 14
-
-
Giaginis, C.1
Daskalopoulou, S.S.2
Vgenopoulou, S.3
Sfiniadakis, I.4
Kouraklis, G.5
-
47
-
-
68949088503
-
Expression and clinical significance of focal adhesion kinase in the two distinct histological types, intestinal and diffuse, of human gastric adenocarcinoma
-
GIAGINIS CT, VGENOPOULOU S, TSOUROUFLIS GS, POLITI EN, KOURAKLIS GP et al. Expression and clinical significance of focal adhesion kinase in the two distinct histological types, intestinal and diffuse, of human gastric adenocarcinoma. Pathol Oncol Res 2009; 15: 173-181. http://dx.doi.org/10.1007/s12253-008-9120-2
-
(2009)
Pathol Oncol Res
, vol.15
, pp. 173-181
-
-
Giaginis, C.T.1
Vgenopoulou, S.2
Tsourouflis, G.S.3
Politi, E.N.4
Kouraklis, G.P.5
-
48
-
-
79952443398
-
MCM-2 and MCM-5 expression in gastric adenocarcinoma: Clinical significance and comparison with Ki-67 proliferative marker
-
GIAGINIS C, GIAGINI A, TSOUROUFLIS G, GATZIDOU E, AGAPITOS E et al. MCM-2 and MCM-5 expression in gastric adenocarcinoma: clinical significance and comparison with Ki-67 proliferative marker. Dig Dis Sci 2011; 56: 777-785. http://dx.doi.org/10.1007/s10620-010-1348-5
-
(2011)
Dig Dis Sci
, vol.56
, pp. 777-785
-
-
Giaginis, C.1
Giagini, A.2
Tsourouflis, G.3
Gatzidou, E.4
Agapitos, E.5
-
49
-
-
11144283115
-
Platelet-activating factor and liver metastasis of colorectal cancer
-
DENIZOT Y, DESCOTTES B, TRUFFINET V, VALLEIX D, LABROUSSE F et al. Platelet-activating factor and liver metastasis of colorectal cancer. Int J Cancer 2005; 113: 503-505. http://dx.doi.org/10.1002/ijc.20585
-
(2005)
Int J Cancer
, vol.113
, pp. 503-505
-
-
Denizot, Y.1
Descottes, B.2
Truffinet, V.3
Valleix, D.4
Labrousse, F.5
-
50
-
-
33750593474
-
Platelet-activating factor and human meningiomas
-
DENIZOT Y, DE ARMAS R, CAIRE F, POMMEPUY I, TRUFFINET V et al. Platelet-activating factor and human meningiomas. Neuropathol Appl Neurobiol 2006; 32: 674-678. http://dx.doi.org/10.1111/j.1365-2990.2006.00775.x
-
(2006)
Neuropathol Appl Neurobiol
, vol.32
, pp. 674-678
-
-
Denizot, Y.1
de Armas, R.2
Caire, F.3
Pommepuy, I.4
Truffinet, V.5
-
51
-
-
0024790416
-
Elevated plasma levels of platelet-activating factor (PAF) in breast cancer patients with hypercalcemia
-
Nigam S, MUller S, Benedetto C. Elevated plasma levels of platelet-activating factor (PAF) in breast cancer patients with hypercalcemia. J Lipid Mediat. 1989; 1: 323-328.
-
(1989)
J Lipid Mediat
, vol.1
, pp. 323-328
-
-
Nigam, S.1
Muller, S.2
Benedetto, C.3
-
52
-
-
33745237674
-
Growth inhibition and differentiation of human breast cancer cells by the PAFR antagonist WEB-2086
-
Cellai C, Laurenzana A, VANNUCCHI AM, CAPORALE R, PAGLIERANI M et al. Growth inhibition and differentiation of human breast cancer cells by the PAFR antagonist WEB-2086. Br J Cancer 2006; 94: 1637-1642.
-
(2006)
Br J Cancer
, vol.94
, pp. 1637-1642
-
-
Cellai, C.1
Laurenzana, A.2
Vannucchi, A.M.3
Caporale, R.4
Paglierani, M.5
-
53
-
-
70249100196
-
Mechanistic insight into WEB-2170-induced apoptosis in human acute myelogenous leukemia cells: The crucial role of PTEN
-
CELLAI C, LAURENZANA A, BIANCHI E, SDELCI S, MAN-FREDINI R et al. Mechanistic insight into WEB-2170-induced apoptosis in human acute myelogenous leukemia cells: the crucial role of PTEN. Exp Hematol 2009; 37: 1176-1185. http://dx.doi.org/10.1016/j.exphem.2009.07.002
-
(2009)
Exp Hematol
, vol.37
, pp. 1176-1185
-
-
Cellai, C.1
Laurenzana, A.2
Bianchi, E.3
Sdelci, S.4
Man-Fredini, R.5
-
54
-
-
2442522289
-
Augmentation of chemotherapy-induced cytokine production by expression of the platelet-activating factor receptor in a human epithelial carcinoma cell line
-
Darst M, Al-Hassani M, Li T, Yi Q, TRAVERS JM et al. Augmentation of chemotherapy-induced cytokine production by expression of the platelet-activating factor receptor in a human epithelial carcinoma cell line. J Immunol 2004; 172: 6330-6335.
-
(2004)
J Immunol
, vol.172
, pp. 6330-6335
-
-
Darst, M.1
Al-Hassani, M.2
Li, T.3
Yi, Q.4
Travers, J.M.5
-
55
-
-
33646392184
-
Platelet-activating factor induces up-regulation of antiapop-totic factors in a melanoma cell line through nuclear factor-κB activation
-
SEO SK, KO HM, KIM HA, CHOI JH, JUN PARK S et al. Platelet-activating factor induces up-regulation of antiapop-totic factors in a melanoma cell line through nuclear factor-κB activation. Cancer Res 2006; 66: 4681-4686. http://dx.doi.org/10.1158/0008-5472.CAN-05-3186
-
(2006)
Cancer Res
, vol.66
, pp. 4681-4686
-
-
Seo, S.K.1
Ko, H.M.2
Kim, H.A.3
Choi, J.H.4
Jun Park, S.5
-
56
-
-
77952038260
-
Platelet-activating factor receptor (PAF-R)-dependent pathways control tumor growth and tumor response to chemotherapy
-
DE Oliveira SI, ANDRADE LN, ONUCHIC AC, NO-NOGAKI S, FERNANDES PD et al. Platelet-activating factor receptor (PAF-R)-dependent pathways control tumor growth and tumor response to chemotherapy. BMC Cancer 2010; 10: 200. http://dx.doi.org/10.1186/1471-2407-10-200
-
(2010)
BMC Cancer
, vol.10
, pp. 200
-
-
de Oliveira, S.I.1
Andrade, L.N.2
Onuchic A.C.No-Nogaki, S.3
Fernandes, P.D.4
|